Enliven Therapeutics (ELVN) Stock Chart & Stock Price History $17.69 -0.21 (-1.17%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$17.64 -0.05 (-0.29%) As of 05:15 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enliven Therapeutics Stock Price Performance The Enliven Therapeutics (ELVN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 17.07%, with a year-to-date return of -21.38%. In the past month, the stock has decreased 21.20%, reflecting recent market activity. As of the latest close, Enliven Therapeutics traded at $17.69 with a market cap of $868.05 million and volume of 574,228 shares. Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.10%1 Month Performance-21.20%3 Month Performance-4.43%Year-To-Date Performance-21.38%1 Year Performance-17.07% ELVN Stock Chart for Monday, August, 11, 2025 ELVN Chart by TradingView Enliven Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$17.90$17.69-1.17%$18.42$17.43574,228 shs$868.05 million08/07/2025$18.84$17.90-4.99%$19.43$17.76345,802 shs$878.34 million08/06/2025$19.22$18.84-1.98%$20.26$18.44390,972 shs$924.48 million08/05/2025$18.74$19.22+2.56%$19.27$18.52516,788 shs$943.13 million08/04/2025$18.73$18.74+0.05%$19.33$18.42273,183 shs$919.55 million08/01/2025$18.81$18.73-0.43%$18.91$18.18490,125 shs$919.06 million07/31/2025$19.32$18.81-2.64%$19.44$18.53409,294 shs$923.01 million07/30/2025$20.07$19.32-3.74%$20.42$19.02304,018 shs$948.03 million07/29/2025$20.67$20.07-2.90%$20.92$19.75243,801 shs$984.82 million07/28/2025$21.20$20.67-2.50%$21.25$20.08338,821 shs$1.01 billion Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$21.95$21.20-3.42%$22.45$21.04183,614 shs$1.04 billion07/24/2025$22.35$21.95-1.79%$22.83$21.80222,821 shs$1.08 billion07/23/2025$21.56$22.35+3.66%$22.37$21.25176,465 shs$1.10 billion07/22/2025$21.87$21.56-1.42%$22.24$21.38278,226 shs$1.06 billion07/21/2025$22.66$21.87-3.49%$23.41$21.79365,050 shs$1.07 billion07/18/2025$23.34$22.66-2.91%$24.38$22.48349,364 shs$1.11 billion07/17/2025$21.46$23.34+8.76%$23.71$21.12792,116 shs$1.15 billion07/16/2025$21.65$21.46-0.88%$22.19$21.38351,211 shs$1.05 billion07/15/2025$23.00$21.65-5.87%$23.44$21.34900,984 shs$1.06 billion07/14/2025$22.45$23.00+2.45%$23.24$21.80416,268 shs$1.13 billion07/11/2025$22.78$22.45-1.45%$23.21$21.99343,523 shs$1.10 billion07/10/2025$21.58$22.78+5.56%$22.87$21.03392,690 shs$1.12 billion Related Companies Viking Therapeutics Stock Chart Metsera Stock Chart SpringWorks Therapeutics Stock Chart Scholar Rock Stock Chart MoonLake Immunotherapeutics Stock Chart Protagonist Therapeutics Stock Chart Ascentage Pharma Group International Stock Chart HUTCHMED Stock Chart Indivior Stock Chart Apellis Pharmaceuticals Stock Chart Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELVN) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access Sale